WealthCare Investment Partners LLC Purchases 281 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

WealthCare Investment Partners LLC boosted its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 2.8% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 10,252 shares of the financial services provider’s stock after acquiring an additional 281 shares during the period. WealthCare Investment Partners LLC’s holdings in iShares Biotechnology ETF were worth $1,458,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Blue Fin Capital Inc. boosted its position in shares of iShares Biotechnology ETF by 0.7% during the 2nd quarter. Blue Fin Capital Inc. now owns 10,516 shares of the financial services provider’s stock valued at $1,443,000 after acquiring an additional 74 shares during the last quarter. Security National Bank of SO Dak grew its stake in iShares Biotechnology ETF by 0.7% in the 2nd quarter. Security National Bank of SO Dak now owns 10,461 shares of the financial services provider’s stock worth $1,436,000 after buying an additional 75 shares in the last quarter. Main Street Financial Solutions LLC increased its holdings in shares of iShares Biotechnology ETF by 1.0% in the 2nd quarter. Main Street Financial Solutions LLC now owns 8,002 shares of the financial services provider’s stock worth $1,098,000 after buying an additional 82 shares during the last quarter. Perkins Coie Trust Co raised its position in shares of iShares Biotechnology ETF by 0.3% during the 2nd quarter. Perkins Coie Trust Co now owns 25,184 shares of the financial services provider’s stock valued at $3,457,000 after buying an additional 83 shares in the last quarter. Finally, HCR Wealth Advisors lifted its holdings in shares of iShares Biotechnology ETF by 0.6% during the 2nd quarter. HCR Wealth Advisors now owns 13,453 shares of the financial services provider’s stock worth $1,847,000 after acquiring an additional 83 shares during the last quarter. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 0.6 %

Shares of NASDAQ:IBB opened at $143.00 on Wednesday. iShares Biotechnology ETF has a 52-week low of $111.83 and a 52-week high of $150.57. The firm has a fifty day moving average of $145.27 and a 200 day moving average of $139.22.

iShares Biotechnology ETF Announces Dividend

The company also recently disclosed a dividend, which was paid on Monday, September 30th. Stockholders of record on Wednesday, September 25th were given a dividend of $0.2005 per share. The ex-dividend date of this dividend was Wednesday, September 25th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.